Netherlands· NL-9a815198c10c
Pergoveris 150 IE/75 IE, poeder en oplosmiddel voor oplossing voor injectie
A gonadotropine, kombinationen product containing follitropine alfa + lutropine alfa , recombinant, registered in Netherlands by Merck Europe B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Gonadotropine, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC G03GA30 (gonadotropine, kombinationen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Gonadotropine, kombinationen · ATC G03GA30
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FOLLITROPINE ALFA + LUTROPINE ALFA , RECOMBINANT
- Manufacturer
- Merck Europe B.V.
- Country
- Netherlands (NL)
- ATC code
- G03GA30
- ATC class
- Gonadotropine, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/07/396
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under G03GA30
Gonadotropine, kombinationen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/30a05b1d-7287-4637-8ea5-4f14ae87db4b GET /v1/drugs/30a05b1d-7287-4637-8ea5-4f14ae87db4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor oplossing voor injectie",
"route": null,
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/pergoveris-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Combinations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73197",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
"FOSFORZUUR (E 338)",
"METHIONINE, (L-)",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"NATRIUMHYDROXIDE (E 524)",
"POLYSORBAAT 20 (E 432)",
"SACCHAROSE",
"WATER VOOR INJECTIE"
],
"substances": [
"FOLLITROPINE ALFA",
"LUTROPINE ALFA , RECOMBINANT"
],
"leaflet_url": null,
"authorised_at": "2007/06/25",
"procedure_number": "EMEA/H/C/000714",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/07/396",
"additional_monitoring": "N"
}See everything about gonadotropine, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.